A Core Center is planned to integrate, coordinate, and foster high quality, interdisciplinary research related to cystic fibrosis by established and newly recruited investigators. The overall objectives of this Center are to determine and understand the primary pathogenetic process, elucidate the pulmonary and exocrine gland pathophysiology, and develop improved methods of management of this disease. The proposed Core Center will provide for expansion of the scientific base for CF research through recruitment and funding of feasibility projects. It will improve integration and coordination of the various CF-related research projects by strengthening a network of core facilities and the administrative structure of the Center. This Core Center will also provide for increased input of information into the research program and expanded communication with other CF research efforts. Twelve new feasibility projects will be integrated with eight program project grants and 14 other independently funded projects to form the Research Program. Two new scientific working groups have evolved (Secretions and Host Defense Mechanisms/Pulmonary Infection). The Center projects will use the nine core facilities, which include a Patient Core of more than 450 CF patients. Additional Core facilities include Administration, Data Processing/Computer, Pulmonary Function, Endoscopy, Microbiology, Morphology, Mucin, and Instrumentation/Service. Recruitment of researchers and communication will be addressed in part through an Enrichment Program of guest lecturers and an Annual Working Conference of invited participants and investigators from this program and other cystic fibrosis research centers. The conference topics will reflect the Core Center's major research areas.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
5P30DK027651-08
Application #
3101997
Study Section
Special Emphasis Panel (SRC)
Project Start
1983-01-01
Project End
1991-03-31
Budget Start
1990-04-01
Budget End
1991-03-31
Support Year
8
Fiscal Year
1990
Total Cost
Indirect Cost
Name
Case Western Reserve University
Department
Type
Schools of Medicine
DUNS #
077758407
City
Cleveland
State
OH
Country
United States
Zip Code
44106
Lai, Nicola; M Kummitha, China; Rosca, Mariana G et al. (2018) Isolation of mitochondrial subpopulations from skeletal muscle: Optimizing recovery and preserving integrity. Acta Physiol (Oxf) :e13182
Donnola, Shannon B; Dasenbrook, Elliott C; Weaver, David et al. (2017) Preliminary comparison of normalized T1 and non-contrast perfusion MRI assessments of regional lung disease in cystic fibrosis patients. J Cyst Fibros 16:283-290
Darrah, Rebecca; Nelson, Rebecca; Damato, Elizabeth G et al. (2016) Growth Deficiency in Cystic Fibrosis Is Observable at Birth and Predictive of Early Pulmonary Function. Biol Res Nurs 18:498-504
VanDevanter, Donald R; Morris, Nathan J; Konstan, Michael W (2016) IV-treated pulmonary exacerbations in the prior year: An important independent risk factor for future pulmonary exacerbation in cystic fibrosis. J Cyst Fibros 15:372-9
VanDevanter, D R; Flume, P A; Morris, N et al. (2016) Probability of IV antibiotic retreatment within thirty days is associated with duration and location of IV antibiotic treatment for pulmonary exacerbation in cystic fibrosis. J Cyst Fibros 15:783-790
Jiang, Kai; Jiao, Sen; Vitko, Megan et al. (2016) The impact of Cystic Fibrosis Transmembrane Regulator Disruption on cardiac function and stress response. J Cyst Fibros 15:34-42
Bruscia, Emanuela M; Bonfield, Tracey L (2016) Cystic Fibrosis Lung Immunity: The Role of the Macrophage. J Innate Immun 8:550-563
Hsu, Daniel; Taylor, Patricia; Fletcher, Dave et al. (2016) Interleukin-17 Pathophysiology and Therapeutic Intervention in Cystic Fibrosis Lung Infection and Inflammation. Infect Immun 84:2410-21
Rymut, Sharon M; Kampman, Claire M; Corey, Deborah A et al. (2016) Ibuprofen regulation of microtubule dynamics in cystic fibrosis epithelial cells. Am J Physiol Lung Cell Mol Physiol 311:L317-27
Than, B L N; Linnekamp, J F; Starr, T K et al. (2016) CFTR is a tumor suppressor gene in murine and human intestinal cancer. Oncogene 35:4179-87

Showing the most recent 10 out of 445 publications